Enleofen was founded as a spin-out from NHCS, SingHealth and Duke-NUS Medical School focused on developing new anti-fibrotic therapies...
Transforming the treatment of fibro-inflammatory diseases Developer of first-in-class therapeutics targeting the IL-11 pathway
Also known as: Enleofen Bio Pte, Enleofen Bio Pte Ltd